Misleading Hepatitis B Serology Following Rho (D) Immune Globulin (Human) Injection and Influenza Vaccine

Xuanxuan Chen

doi:10.4081/cp.2018.1037

You are currently viewing a new version of our website. To view the old version click .

Clinics and Practice is published by MDPI from Volume 11 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.

Case Report

21 March 2018

Misleading Hepatitis B Serology Following Rho (D) Immune Globulin (Human) Injection and Influenza Vaccine

Department of Anaesthesiology, Singapore General Hospital, Singapore

Clin. Pract.2018, 8(2), 1037;https://doi.org/10.4081/cp.2018.1037

Version Notes

Order Reprints

Abstract

Having a hepatitis B surface antibody (HBsAb) titre of more than 10 mIU/mL after hepatitis B vaccination is generally considered to confer immunity to hepatitis B. This case report discusses an unusual case of a false positive hepatitis B core total antibody (HBcAb) following administration of either Rho (D) immune globulin (Human) injection or influenza vaccine in a patriuent who was previously immunised against hepatitis B.

Keywords:

Rho (D); immune globulin (human); injection; influenza vaccine; hepatitis B core total antibody

Article Metrics

Citations

Article Access Statistics

Journal Statistics

Multiple requests from the same IP address are counted as one view.

Rectal Leiomyoma, a Rare Entity

Early Prenatal Diagnosis of Parapagus Conjoined Twins